We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA’s Revised Marketing and CME Code for Drugmakers Emphasizes Disclosure
PhRMA’s Revised Marketing and CME Code for Drugmakers Emphasizes Disclosure
July 11, 2008
Drugmakers need to require consultants who are members of committees that develop clinical guidelines or set formularies to disclose their corporate relationships to the committees, according to a marketing code of conduct just revised by PhRMA.